 Safety-Based Drug Withdrawals
"Safety-Based Drug Withdrawals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Removal of a drug from the market due to the identification of an intrinsic property of the drug that results in a serious risk to public health.
| Descriptor ID |
D056737
|
| MeSH Number(s) |
I01.880.604.605.250.812 N04.452.706.310.750 N06.850.210.637.700
|
| Concept/Terms |
Safety-Based Drug Withdrawals- Safety-Based Drug Withdrawals
- Drug Withdrawal, Safety-Based
- Drug Withdrawals, Safety-Based
- Safety Based Drug Withdrawals
- Drug Withdrawals Due to Safety
- Safety-Based Drug Withdrawal
- Safety Based Drug Withdrawal
- Drug Withdrawal Due to Safety
|
Below are MeSH descriptors whose meaning is more general than "Safety-Based Drug Withdrawals".
Below are MeSH descriptors whose meaning is more specific than "Safety-Based Drug Withdrawals".
This graph shows the total number of publications written about "Safety-Based Drug Withdrawals" by people in this website by year, and whether "Safety-Based Drug Withdrawals" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Safety-Based Drug Withdrawals" by people in Profiles.
-
MacNeil JR, Su JR, Broder KR, Guh AY, Gargano JW, Wallace M, Hadler SC, Scobie HM, Blain AE, Moulia D, Daley MF, McNally VV, Romero JR, Talbot HK, Lee GM, Bell BP, Oliver SE. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 30; 70(17):651-656.
-
Wang Z, Zheng Q, Zhang H, Bronson RT, Madsen JC, Sachs DH, Huang CA, Wang Z. Ontak-like human IL-2 fusion toxin. J Immunol Methods. 2017 09; 448:51-58.
-
Hiatt WR, Kaul S, Smith RJ. The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience. N Engl J Med. 2013 Oct 03; 369(14):1285-7.
-
Goo R, Miller M, McArthur T. Provider compliance with the Food and Drug Administration recommendation to avoid the use of over-the-counter (nonprescription) cough and cold medications in children younger than 2 years. Clin Pediatr (Phila). 2010 Apr; 49(4):384-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|